METTL3 and non-small cell lung carcinoma: Furthermore, Mettl3 SUMOylation has been preliminary identified to enhance tumor growth in human non-small cell lung carcinoma cell line H1299 24, but the role of Mettl3 SUMOylation in liver cancer progression and the underlying regulatory mechanisms of tumorigenesis have yet to be elucidated.